Abstract
To the Editor: In several surgical subspecialties, opioid prescribing guidelines help clinicians manage the patient's postoperative pain while minimizing the risks associated with opioid use.1 In 2020 and 2021, 2 dermatologic surgery-specific opioid prescribing guidelines were introduced.2,3 They provide guidance as to which dermatologic procedures necessitate opioids for pain control. In the 2020 guidelines by Donigan et al,2 a consensus was reached to not routinely prescribe opioids for most complex linear repairs (CLCs) (excluding the nail unit and scalp >2.5 cm) or <20 cm2 full-thickness skin grafts (FTSG) after Mohs micrographic surgery (MMS).
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
